Ocean Tomo Bolsters IP Litigation Expertise with Former FDA Economist
Event summary
- Nikki Tavasoli, PhD, a former economist at the FDA, has joined Ocean Tomo, a subsidiary of J.S. Held.
- Tavasoli specializes in econometric modeling, machine learning, and causal inference, particularly within regulatory contexts.
- Her prior work includes analyzing generic drug life cycles, opioid pricing models, and the economic effects of substance bans.
- Ocean Tomo is positioned as an intellectual property (IP) valuation and advisory firm.
- J.S. Held serves a wide range of clients, including Global 200 Law Firms, major insurance companies, and Fortune 100 companies.
The big picture
The addition of a former FDA economist signals a strategic move by J.S. Held/Ocean Tomo to deepen its expertise in the increasingly complex intersection of intellectual property, regulatory compliance, and economic litigation within the life sciences sector. This hire is likely a response to growing pressure on pharmaceutical pricing and heightened antitrust enforcement, creating a need for sophisticated economic analysis and expert testimony. The firm’s broad client base across legal and corporate sectors suggests a significant opportunity to leverage this expertise for substantial revenue generation.
What we're watching
- Litigation Impact
- The extent to which Tavasoli's expertise directly influences the outcomes of ongoing or future IP disputes for J.S. Held's clients will be a key indicator of the hire's value.
- Regulatory Scrutiny
- Increased regulatory scrutiny of drug pricing and market competition, a domain of Tavasoli's prior experience, could create further demand for J.S. Held's services.
- Model Adoption
- The pace at which J.S. Held integrates Tavasoli’s advanced modeling techniques into its existing valuation and advisory processes will determine the firm’s competitive advantage.
Related topics